Clinical Trial Update: IMMUNOPLANT for Newly Diagnosed Multiple Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating IMMUNOPLANT for newly diagnosed multiple myeloma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• IMMUNOPLANT

Snippet

Sponsor: Dickran Kazandjian, MD | Conditions: Multiple Myeloma | Phase 2 | Status: RECRUITING